Table of Content

1 Romiplostim Injection Market Overview
1.1 Product Overview and Scope of Romiplostim Injection
1.2 Romiplostim Injection Segment by Type
1.2.1 Global Romiplostim Injection Market Value Comparison by Type (2024-2034)
1.2.2 250 μg/0.5 mL
1.2.3 500 μg/1 mL
1.3 Romiplostim Injection Segment by Application
1.3.1 Global Romiplostim Injection Market Value by Application: (2024-2034)
1.3.2 Adults
1.3.3 Pediatric Patients
1.4 Global Romiplostim Injection Market Size Estimates and Forecasts
1.4.1 Global Romiplostim Injection Revenue 2018-2029
1.4.2 Global Romiplostim Injection Sales 2018-2029
1.4.3 Global Romiplostim Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Romiplostim Injection Market Competition by Manufacturers
2.1 Global Romiplostim Injection Sales Market Share by Manufacturers (2018-2024)
2.2 Global Romiplostim Injection Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Romiplostim Injection Average Price by Manufacturers (2018-2024)
2.4 Global Romiplostim Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Romiplostim Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Romiplostim Injection, Product Type & Application
2.7 Romiplostim Injection Market Competitive Situation and Trends
2.7.1 Romiplostim Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Romiplostim Injection Players Market Share by Revenue
2.7.3 Global Romiplostim Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Romiplostim Injection Retrospective Market Scenario by Region
3.1 Global Romiplostim Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Romiplostim Injection Global Romiplostim Injection Sales by Region: 2018-2029
3.2.1 Global Romiplostim Injection Sales by Region: 2018-2024
3.2.2 Global Romiplostim Injection Sales by Region: 2024-2029
3.3 Global Romiplostim Injection Global Romiplostim Injection Revenue by Region: 2018-2029
3.3.1 Global Romiplostim Injection Revenue by Region: 2018-2024
3.3.2 Global Romiplostim Injection Revenue by Region: 2024-2029
3.4 North America Romiplostim Injection Market Facts & Figures by Country
3.4.1 North America Romiplostim Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Romiplostim Injection Sales by Country (2018-2029)
3.4.3 North America Romiplostim Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Romiplostim Injection Market Facts & Figures by Country
3.5.1 Europe Romiplostim Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Romiplostim Injection Sales by Country (2018-2029)
3.5.3 Europe Romiplostim Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Romiplostim Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Romiplostim Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Romiplostim Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Romiplostim Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Romiplostim Injection Market Facts & Figures by Country
3.7.1 Latin America Romiplostim Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Romiplostim Injection Sales by Country (2018-2029)
3.7.3 Latin America Romiplostim Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Romiplostim Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Romiplostim Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Romiplostim Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Romiplostim Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Romiplostim Injection Sales by Type (2018-2029)
4.1.1 Global Romiplostim Injection Sales by Type (2018-2024)
4.1.2 Global Romiplostim Injection Sales by Type (2024-2029)
4.1.3 Global Romiplostim Injection Sales Market Share by Type (2018-2029)
4.2 Global Romiplostim Injection Revenue by Type (2018-2029)
4.2.1 Global Romiplostim Injection Revenue by Type (2018-2024)
4.2.2 Global Romiplostim Injection Revenue by Type (2024-2029)
4.2.3 Global Romiplostim Injection Revenue Market Share by Type (2018-2029)
4.3 Global Romiplostim Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Romiplostim Injection Sales by Application (2018-2029)
5.1.1 Global Romiplostim Injection Sales by Application (2018-2024)
5.1.2 Global Romiplostim Injection Sales by Application (2024-2029)
5.1.3 Global Romiplostim Injection Sales Market Share by Application (2018-2029)
5.2 Global Romiplostim Injection Revenue by Application (2018-2029)
5.2.1 Global Romiplostim Injection Revenue by Application (2018-2024)
5.2.2 Global Romiplostim Injection Revenue by Application (2024-2029)
5.2.3 Global Romiplostim Injection Revenue Market Share by Application (2018-2029)
5.3 Global Romiplostim Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Romiplostim Injection Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Amgen Romiplostim Injection Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Kyowa Kirin
6.2.1 Kyowa Kirin Corporation Information
6.2.2 Kyowa Kirin Description and Business Overview
6.2.3 Kyowa Kirin Romiplostim Injection Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Kyowa Kirin Romiplostim Injection Product Portfolio
6.2.5 Kyowa Kirin Recent Developments/Updates
6.3 Intas Pharmaceuticals
6.3.1 Intas Pharmaceuticals Corporation Information
6.3.2 Intas Pharmaceuticals Description and Business Overview
6.3.3 Intas Pharmaceuticals Romiplostim Injection Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Intas Pharmaceuticals Romiplostim Injection Product Portfolio
6.3.5 Intas Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Romiplostim Injection Industry Chain Analysis
7.2 Romiplostim Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Romiplostim Injection Production Mode & Process
7.4 Romiplostim Injection Sales and Marketing
7.4.1 Romiplostim Injection Sales Channels
7.4.2 Romiplostim Injection Distributors
7.5 Romiplostim Injection Customers
8 Romiplostim Injection Market Dynamics
8.1 Romiplostim Injection Industry Trends
8.2 Romiplostim Injection Market Drivers
8.3 Romiplostim Injection Market Challenges
8.4 Romiplostim Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Romiplostim Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Romiplostim Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Romiplostim Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Romiplostim Injection Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Romiplostim Injection Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Romiplostim Injection Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Romiplostim Injection Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Romiplostim Injection Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Romiplostim Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Romiplostim Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Romiplostim Injection, Product Type & Application
Table 12. Global Key Manufacturers of Romiplostim Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Romiplostim Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Romiplostim Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Romiplostim Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Romiplostim Injection Sales by Region (2018-2024) & (K Units)
Table 18. Global Romiplostim Injection Sales Market Share by Region (2018-2024)
Table 19. Global Romiplostim Injection Sales by Region (2024-2029) & (K Units)
Table 20. Global Romiplostim Injection Sales Market Share by Region (2024-2029)
Table 21. Global Romiplostim Injection Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Romiplostim Injection Revenue Market Share by Region (2018-2024)
Table 23. Global Romiplostim Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Romiplostim Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Romiplostim Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Romiplostim Injection Sales by Country (2018-2024) & (K Units)
Table 27. North America Romiplostim Injection Sales by Country (2024-2029) & (K Units)
Table 28. North America Romiplostim Injection Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Romiplostim Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Romiplostim Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Romiplostim Injection Sales by Country (2018-2024) & (K Units)
Table 32. Europe Romiplostim Injection Sales by Country (2024-2029) & (K Units)
Table 33. Europe Romiplostim Injection Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Romiplostim Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Romiplostim Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Romiplostim Injection Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Romiplostim Injection Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Romiplostim Injection Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Romiplostim Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Romiplostim Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Romiplostim Injection Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Romiplostim Injection Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Romiplostim Injection Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Romiplostim Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Romiplostim Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Romiplostim Injection Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Romiplostim Injection Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Romiplostim Injection Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Romiplostim Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Romiplostim Injection Sales (K Units) by Type (2018-2024)
Table 51. Global Romiplostim Injection Sales (K Units) by Type (2024-2029)
Table 52. Global Romiplostim Injection Sales Market Share by Type (2018-2024)
Table 53. Global Romiplostim Injection Sales Market Share by Type (2024-2029)
Table 54. Global Romiplostim Injection Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Romiplostim Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Romiplostim Injection Revenue Market Share by Type (2018-2024)
Table 57. Global Romiplostim Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Romiplostim Injection Price (US$/Unit) by Type (2018-2024)
Table 59. Global Romiplostim Injection Price (US$/Unit) by Type (2024-2029)
Table 60. Global Romiplostim Injection Sales (K Units) by Application (2018-2024)
Table 61. Global Romiplostim Injection Sales (K Units) by Application (2024-2029)
Table 62. Global Romiplostim Injection Sales Market Share by Application (2018-2024)
Table 63. Global Romiplostim Injection Sales Market Share by Application (2024-2029)
Table 64. Global Romiplostim Injection Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Romiplostim Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Romiplostim Injection Revenue Market Share by Application (2018-2024)
Table 67. Global Romiplostim Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Romiplostim Injection Price (US$/Unit) by Application (2018-2024)
Table 69. Global Romiplostim Injection Price (US$/Unit) by Application (2024-2029)
Table 70. Amgen Corporation Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen Romiplostim Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Amgen Romiplostim Injection Product
Table 74. Amgen Recent Developments/Updates
Table 75. Kyowa Kirin Corporation Information
Table 76. Kyowa Kirin Description and Business Overview
Table 77. Kyowa Kirin Romiplostim Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Kyowa Kirin Romiplostim Injection Product
Table 79. Kyowa Kirin Recent Developments/Updates
Table 80. Intas Pharmaceuticals Corporation Information
Table 81. Intas Pharmaceuticals Description and Business Overview
Table 82. Intas Pharmaceuticals Romiplostim Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Intas Pharmaceuticals Romiplostim Injection Product
Table 84. Intas Pharmaceuticals Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Romiplostim Injection Distributors List
Table 88. Romiplostim Injection Customers List
Table 89. Romiplostim Injection Market Trends
Table 90. Romiplostim Injection Market Drivers
Table 91. Romiplostim Injection Market Challenges
Table 92. Romiplostim Injection Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Romiplostim Injection
Figure 2. Global Romiplostim Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Romiplostim Injection Market Share by Type in 2022 & 2029
Figure 4. 250 μg/0.5 mL Product Picture
Figure 5. 500 μg/1 mL Product Picture
Figure 6. Global Romiplostim Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Romiplostim Injection Market Share by Application in 2022 & 2029
Figure 8. Adults
Figure 9. Pediatric Patients
Figure 10. Global Romiplostim Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Romiplostim Injection Market Size (2018-2029) & (US$ Million)
Figure 12. Global Romiplostim Injection Sales (2018-2029) & (K Units)
Figure 13. Global Romiplostim Injection Average Price (US$/Unit) & (2018-2029)
Figure 14. Romiplostim Injection Report Years Considered
Figure 15. Romiplostim Injection Sales Share by Manufacturers in 2022
Figure 16. Global Romiplostim Injection Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Romiplostim Injection Players: Market Share by Revenue in 2022
Figure 18. Romiplostim Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Romiplostim Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Romiplostim Injection Sales Market Share by Country (2018-2029)
Figure 21. North America Romiplostim Injection Revenue Market Share by Country (2018-2029)
Figure 22. United States Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Romiplostim Injection Sales Market Share by Country (2018-2029)
Figure 25. Europe Romiplostim Injection Revenue Market Share by Country (2018-2029)
Figure 26. Germany Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Romiplostim Injection Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Romiplostim Injection Revenue Market Share by Region (2018-2029)
Figure 33. China Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Romiplostim Injection Sales Market Share by Country (2018-2029)
Figure 41. Latin America Romiplostim Injection Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Romiplostim Injection Sales Market Share by Country (2018-2029)
Figure 46. Middle East & Africa Romiplostim Injection Revenue Market Share by Country (2018-2029)
Figure 47. Turkey Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. UAE Romiplostim Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Global Sales Market Share of Romiplostim Injection by Type (2018-2029)
Figure 51. Global Revenue Market Share of Romiplostim Injection by Type (2018-2029)
Figure 52. Global Romiplostim Injection Price (US$/Unit) by Type (2018-2029)
Figure 53. Global Sales Market Share of Romiplostim Injection by Application (2018-2029)
Figure 54. Global Revenue Market Share of Romiplostim Injection by Application (2018-2029)
Figure 55. Global Romiplostim Injection Price (US$/Unit) by Application (2018-2029)
Figure 56. Romiplostim Injection Value Chain
Figure 57. Romiplostim Injection Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed